Considerations for mRNA-LNP Potency Assay Development for Gene Editing Products - 12 de marzo de 2026 - TecnoWebinars.comPresented by Benjamin Hall, Associate Director in Analytical Development at Tessera Therapeutics
| ¿Le gustaría hacer webinars o eventos online con nosotros?
|